GISELLE MERY M.D. NPI 1295747624

NPI Details

Giselle Mery, M.D. is a medical oncology internal medicine in Des Moines, IA with 29 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Giselle Mery, M.D. NPI is 1295747624. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NEW YORK MEDICAL COLLEGE
Graduation Year:1996

The provider's business location address is:

411 LAUREL ST STE A300
DES MOINES, IA
ZIP 50314-030
Phone: (515) 282-2921

The NPI 1295747624 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Phosphate level (HCPCS:84100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection of drug or substance into vein (HCPCS:96374)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Ct scan of chest without contrast (HCPCS:71250)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)

The enumeration date for this NPI number is 8/13/2006 and was last updated on 2/4/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.